bpc 157 safety evidence clinical trials Here's a nice graphic on BPC-157 that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D What no one's telling you
Description
we're trying to rebuild a foundational structure
Current Pharmaceutical Design, 2011
Our commitment to quality extends beyond the small-batch synthesis of our products
Combined NNMT inhibitor treatment with reduced-calorie diet achieved 6.3 g cumulative weight loss versus 2.9 g with diet alone, and fat mass reduction was ten-fold greater with treatment (~29.3%) compared to diet switch alone (2.9%), while restoring fatty liver profiles to lean-control levels (Sampson et al., 2021)
